{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:27:11Z","timestamp":1772641631243,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"DOI":"10.1186\/s13011-026-00706-9","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T13:54:28Z","timestamp":1770213268000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between the location of Opioid Agonist Treatment (OAT) providers and heroin-related ambulance attendances"],"prefix":"10.1186","volume":"21","author":[{"given":"Natasha","family":"Hall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bosco","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rowan P.","family":"Ogeil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rick","family":"Loos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziad","family":"Nehme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan I.","family":"Lubman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"issue":"1","key":"706_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","volume":"106","author":"L Degenhardt","year":"2011","unstructured":"Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2011;106(1):32\u201351.","journal-title":"Addiction"},{"key":"706_CR2","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1136\/bmj.j1550","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:1550.","journal-title":"BMJ"},{"key":"706_CR3","doi-asserted-by":"crossref","unstructured":"Fullerton CA, Kim M, Thomas CP, Lyman R, Montejano LB, Dougherty RH, et al. Medication-Assisted treatment with methadone: assessing the evidence. Psychiatric Serv. 2014(2):146.","DOI":"10.1176\/appi.ps.201300235"},{"issue":"4","key":"706_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/acps.13088","volume":"140","author":"A Bahji","year":"2019","unstructured":"Bahji A, Cheng B, Gray S, Stuart H. Reduction in mortality risk with opioid agonist therapy: a systematic review and meta-analysis. Acta Psychiatrica Scandinavica. 2019;140(4):313\u201339.","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"5","key":"706_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/emermed-2022-212755","volume":"40","author":"M Curtis","year":"2023","unstructured":"Curtis M, Wilkinson AL, Dietze P, Stewart AC, Kinner SA, Cossar RD, et al. Prospective study of retention in opioid agonist treatment and contact with emergency healthcare following release from prisons in Victoria, Australia. Emerg Med J. 2023;40(5):347.","journal-title":"Emerg Med J"},{"issue":"6","key":"706_CR6","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/dar.12976","volume":"38","author":"NR Jones","year":"2019","unstructured":"Jones NR, Shanahan M, Dobbins T, Degenhardt L, Montebello M, Gisev N, et al. Reductions in emergency department presentations associated with opioid agonist treatment vary by geographic location: A retrospective study in new South Wales, Australia. Drug Alcohol Rev. 2019;38(6):690\u20138.","journal-title":"Drug Alcohol Rev"},{"issue":"10","key":"706_CR7","doi-asserted-by":"publisher","first-page":"e0258620","DOI":"10.1371\/journal.pone.0258620","volume":"16","author":"N Hall","year":"2021","unstructured":"Hall N, Le L, Majmudar I, Teesson M, Mihalopoulos C. Treatment-seeking behaviour among people with opioid use disorder in the high-income countries: A systematic review and meta-analysis. PLoS ONE. 2021;16(10):e0258620.","journal-title":"PLoS ONE"},{"key":"706_CR8","doi-asserted-by":"publisher","first-page":"108651","DOI":"10.1016\/j.drugalcdep.2021.108651","volume":"221","author":"NY Hall","year":"2021","unstructured":"Hall NY, Le L, Majmudar I, Mihalopoulos C. Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective. Drug Alcohol Depend. 2021;221:108651.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"706_CR9","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/dar.12268","volume":"34","author":"R Khampang","year":"2015","unstructured":"Khampang R, Assanangkornchai S, Teerawattananon Y. Perceived barriers to utilise methadone maintenance therapy among male injection drug users in rural areas of Southern Thailand. Drug Alcohol Rev. 2015;34(6):645\u201353.","journal-title":"Drug Alcohol Rev"},{"key":"706_CR10","unstructured":"NSW Health. NSW Opioid Treatment Program (OTP) Sydney: NSW Health. 2024 [updated 20\/02\/2024]. Available from: https:\/\/www.health.nsw.gov.au\/pharmaceutical\/doctors\/Pages\/otp-medical-practitioners.aspx"},{"issue":"1","key":"706_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12875-024-02474-6","volume":"25","author":"HHK Wilson","year":"2024","unstructured":"Wilson HHK, Roxas BH, Lintzeris N, Harris MF. Diagnosing and managing prescription opioid use disorder in patients prescribed opioids for chronic pain in Australian general practice settings: a qualitative study using the theory of planned behaviour. BMC Prim Care. 2024;25(1):236.","journal-title":"BMC Prim Care"},{"key":"706_CR12","doi-asserted-by":"publisher","first-page":"108464","DOI":"10.1016\/j.drugalcdep.2020.108464","volume":"219","author":"NR Jones","year":"2021","unstructured":"Jones NR, Nielsen S, Farrell M, Ali R, Gill A, Larney S, et al. Retention of opioid agonist treatment prescribers across new South Wales, Australia, 2001\u20132018: implications for treatment systems and potential impact on client outcomes. Drug Alcohol Depend. 2021;219:108464.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"706_CR13","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1080\/10826084.2017.1325376","volume":"53","author":"JD Livingston","year":"2018","unstructured":"Livingston JD, Erica A, Marlee J, Zachary M, Hering R. Primary care physicians\u2019 views about prescribing methadone to treat opioid use disorder. Subst Use Misuse. 2018;53(2):344\u201353.","journal-title":"Subst Use Misuse"},{"issue":"3","key":"706_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s11469-013-9436-3","volume":"12","author":"MC Van Hout","year":"2014","unstructured":"Van Hout MC, Bingham T. A qualitative study of prescribing Doctor experiences of methadone maintenance treatment. Int J Mental Health Addict. 2014;12(3):227\u201342.","journal-title":"Int J Mental Health Addict"},{"key":"706_CR15","unstructured":"Australian Institute of Health and Welfare. National Opioid Pharmacotherapy Statistics Annual Data Collection Data Table 2024. Canberra. 2024."},{"key":"706_CR16","unstructured":"Pharmacy Guild of Australia. Vital facts on community pharmacy Victoria. 2024. [Available from: https:\/\/www.guild.org.au\/__data\/assets\/pdf_file\/0028\/132994\/PharmacyGuild-Vital-facts-on-Community-Pharmacy-November_v2.pdf]"},{"issue":"4","key":"706_CR17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/dar.12032","volume":"32","author":"BB Chaar","year":"2013","unstructured":"Chaar BB, Wang H, Day CA, Hanrahan JR, Winstock AR, Fois R. Factors influencing pharmacy services in opioid substitution treatment. Drug Alcohol Rev. 2013;32(4):426\u201334.","journal-title":"Drug Alcohol Rev"},{"issue":"4","key":"706_CR18","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/dar.14069","volume":"44","author":"JH Conigrave","year":"2025","unstructured":"Conigrave JH, Dobbins T, Buckley NA, Lee KSK, Morley KC, Doyle M, et al. Disparities in opioid agonist treatment accessibility for priority populations in new South Wales, Australia. Drug Alcohol Rev. 2025;44(4):975\u201382.","journal-title":"Drug Alcohol Rev"},{"key":"706_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jsat.2018.07.006","volume":"93","author":"S Amiri","year":"2018","unstructured":"Amiri S, Lutz R, Soc\u00edas ME, McDonell MG, Roll JM, Amram O. Increased distance was associated with lower daily attendance to an opioid treatment program in Spokane County Washington. J Subst Abuse Treat. 2018;93:26\u201330.","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"706_CR20","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s12913-022-07886-7","volume":"22","author":"A Alibrahim","year":"2022","unstructured":"Alibrahim A, Marsh JC, Amaro H, Kong Y, Khachikian T, Guerrero E. Disparities in expected driving time to opioid treatment and treatment completion: findings from an exploratory study. BMC Health Serv Res. 2022;22(1):478.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"706_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/10826084.2014.958860","volume":"50","author":"E Murphy","year":"2015","unstructured":"Murphy E, Comiskey CM. Modeling the impact of place on individual methadone treatment outcomes in a National longitudinal cohort study. Subst Use Misuse. 2015;50(1):99\u2013105.","journal-title":"Subst Use Misuse"},{"key":"706_CR22","unstructured":"Black Dog Institute. Care After a Suicide Attempt. Sydney: Black Dog Institute. 2020 April 2020."},{"key":"706_CR23","unstructured":"Lubman D, Lloyd B, Scott D, McCann T, Savic M, Witt K, et al. Beyond Emerg. 2019."},{"issue":"6","key":"706_CR24","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1177\/09697330221149102","volume":"30","author":"S Hammarb\u00e4ck","year":"2023","unstructured":"Hammarb\u00e4ck S, Holmberg M, Wiklund Gustin L, Bremer A. Ambulance clinicians\u2019 responsibility when encountering patients in a suicidal process. Nurs Ethics. 2023;30(6):857\u201370.","journal-title":"Nurs Ethics"},{"issue":"1","key":"706_CR25","doi-asserted-by":"publisher","first-page":"e0228316","DOI":"10.1371\/journal.pone.0228316","volume":"15","author":"DI Lubman","year":"2020","unstructured":"Lubman DI, Matthews S, Heilbronn C, Killian JJ, Ogeil RP, Lloyd B, et al. The National ambulance surveillance system: A novel method for monitoring acute alcohol, illicit and pharmaceutical drug related-harms using coded Australian ambulance clinical records. PLoS ONE. 2020;15(1):e0228316.","journal-title":"PLoS ONE"},{"key":"706_CR26","doi-asserted-by":"crossref","unstructured":"Roggenkamp R, Emily A, Ziad N, Shelley C, Smith K. Prehospital Emerg Care. 2018;22(4):399\u2013405. Descriptive Analysis Of Mental Health-Related Presentations To Emergency Medical Services.","DOI":"10.1080\/10903127.2017.1399181"},{"issue":"1","key":"706_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13049-019-0611-9","volume":"27","author":"EAS Duncan","year":"2019","unstructured":"Duncan EAS, Best C, Dougall N, Skar S, Evans J, Corfield AR, et al. Epidemiology of emergency ambulance service calls related to mental health problems and self harm: a National record linkage study. Scand J Trauma Resusc Emerg Med. 2019;27(1):34.","journal-title":"Scand J Trauma Resusc Emerg Med"},{"issue":"4","key":"706_CR28","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1071\/AH24067","volume":"48","author":"N Goyal","year":"2024","unstructured":"Goyal N, Proper E, Lin P, Ahmad U, John-White M, O\u2019Reilly GM, et al. Using emergency department data to define a \u2018mental health presentation\u2019 - implications of different definitions on estimates of emergency department mental health workload. Aust Health Rev. 2024;48(4):342\u201350.","journal-title":"Aust Health Rev"},{"issue":"3","key":"706_CR29","doi-asserted-by":"publisher","first-page":"e33012303","DOI":"10.17061\/phrp33012303","volume":"33","author":"G Sara","year":"2023","unstructured":"Sara G, Wu J. Enhanced self-harm presentation reporting using additional ICD-10 codes and free text in NSW emergency departments. Public Health Res Pract. 2023;33(3):e33012303. https:\/\/doi.org\/10.17061\/phrp33012303.","journal-title":"Public Health Res Pract"},{"issue":"7","key":"706_CR30","doi-asserted-by":"publisher","first-page":"e0236344","DOI":"10.1371\/journal.pone.0236344","volume":"15","author":"DI Lubman","year":"2020","unstructured":"Lubman DI, Heilbronn C, Ogeil RP, Killian JJ, Matthews S, Smith K, et al. National ambulance surveillance system: a novel method using coded Australian ambulance clinical records to monitor self-harm and mental health-related morbidity. PLoS ONE. 2020;15(7):e0236344.","journal-title":"PLoS ONE"},{"key":"706_CR31","doi-asserted-by":"publisher","first-page":"103461","DOI":"10.1016\/j.healthplace.2025.103461","volume":"93","author":"SY Choo","year":"2025","unstructured":"Choo SY, Wilson J, Beard N, McGrath M, Lubman DI, Smith K, et al. Patterns of intimate partner violence in Victoria, Australia: analysis using the National ambulance surveillance system. Health Place. 2025;93:103461.","journal-title":"Health Place"},{"key":"706_CR32","unstructured":"Turning Point. DirectLine Melbourne: Turning Point. 2024. [Available from: https:\/\/www.directline.org.au\/]"},{"key":"706_CR33","unstructured":"Department of Environment L, Water and Planning. Metropolitan Melbourne regions Melbourne: Victorian Department of Environment, Land, Water and Planning 2017; 2017. [Available from: https:\/\/www.planning.vic.gov.au\/__data\/assets\/pdf_file\/0026\/628361\/plan-melbourne-map-metro-melbourne-regions.pdf]"},{"key":"706_CR34","unstructured":"Australian Bureau of Statistics. Socio-Economic Indexes for Areas (SEIFA), Australia Canberra: Australian Bureau of Statistics; 2023. [Available from: https:\/\/www.abs.gov.au\/statistics\/people\/people-and-communities\/socio-economic-indexes-areas-seifa-australia\/latest-release#data-downloads]"},{"key":"706_CR35","unstructured":"Department of Health and Aged Care. Rural, Remote and Metropolitan Area Canberra: Australian Government; 2021 [updated 14\/12\/2021]. Available from: https:\/\/www.health.gov.au\/topics\/rural-health-workforce\/classifications\/rrma"},{"key":"706_CR36","doi-asserted-by":"crossref","unstructured":"West BT, Welch KB, Galecki AT. Linear mixed models: a practical guide using statistical software. Chapman and Hall\/CRC; 2022.","DOI":"10.1201\/9781003181064"},{"key":"706_CR37","unstructured":"Australian Criminal Intelligence Commission. National Wastewater Drug Monitoring Program Report 21. Canberra; 2024."},{"key":"706_CR38","unstructured":"Australian Institute of Health and Welfare. Alcohol, tobacco & other drugs in Australia Canberra: AIHW. 2024 [Available from: https:\/\/www.aihw.gov.au\/reports\/alcohol\/alcohol-tobacco-other-drugs-australia\/contents\/drug-types\/illicit-opioids-including-heroin]"},{"issue":"1","key":"706_CR39","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40360-018-0219-0","volume":"19","author":"MM Islam","year":"2018","unstructured":"Islam MM, McRae IS, Mazumdar S, Simpson P, Wollersheim D, Fatema K, et al. Prescription opioid dispensing in New South Wales, Australia: Spatial and Temporal variation. BMC Pharmacol Toxicol. 2018;19(1):30.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"5","key":"706_CR40","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/pds.3931","volume":"25","author":"L Degenhardt","year":"2016","unstructured":"Degenhardt L, Gisev N, Cama E, Nielsen S, Larance B, Bruno R. The extent and correlates of community-based pharmaceutical opioid utilisation in Australia. Pharmacoepidemiol Drug Saf. 2016;25(5):521\u201338.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"706_CR41","volume-title":"Regression models for categorical dependent variables using Stata","author":"JS Long","year":"2014","unstructured":"Long JS, Freese J. Regression models for categorical dependent variables using Stata. Third Edition: Stata; 2014."},{"issue":"4","key":"706_CR42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/YCO.0000000000000943","volume":"37","author":"A Cheetham","year":"2024","unstructured":"Cheetham A, Grist E, Nielsen S. Pharmacist-prescriber collaborative models of care for opioid use disorder: an overview of recent research. Curr Opin Psychiatry. 2024;37(4):251\u20137.","journal-title":"Curr Opin Psychiatry"},{"issue":"3","key":"706_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/00952990.2019.1694536","volume":"46","author":"JJ Lister","year":"2020","unstructured":"Lister JJ, Weaver A, Ellis JD, Himle JA, Ledgerwood DM. A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States. Am J Drug Alcohol Abus. 2020;46(3):273\u201388.","journal-title":"Am J Drug Alcohol Abus"},{"key":"706_CR44","unstructured":"Australian Institute of Criminology. Researching heroin supply. Canberra; 2003."},{"issue":"4","key":"706_CR45","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/09581590400027528","volume":"14","author":"I van Beek","year":"2004","unstructured":"van Beek I, Kimber J, Dakin A, Gilmour S. The Sydney medically supervised injecting centre: reducing harm associated with heroin overdose. Crit Public Health. 2004;14(4):391\u2013406.","journal-title":"Crit Public Health"},{"issue":"5","key":"706_CR46","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.amepre.2021.04.017","volume":"61","author":"TW Levengood","year":"2021","unstructured":"Levengood TW, Yoon GH, Davoust MJ, Ogden SN, Marshall BDL, Cahill SR, et al. Supervised injection facilities as harm reduction: a systematic review. Am J Prev Med. 2021;61(5):738\u201349.","journal-title":"Am J Prev Med"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13011-026-00706-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-026-00706-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-026-00706-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T11:38:12Z","timestamp":1772624292000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13011-026-00706-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["706"],"URL":"https:\/\/doi.org\/10.1186\/s13011-026-00706-9","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"19 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethical approval from the Eastern Health Research Ethics Committee (ethics approval: E122-0809-14552). The Eastern Health Human Research Ethics Committee acts in accordance with the by-laws of Eastern Health, and operates within the guidelines of the Australian National Health and Medical Research Council (NHMRC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All manuscript authors, Natasha Hall, Bosco Rowland, Rowan Ogeil, Rick Loos, Ziad Nehme and Dan Lubman, provide consent for their work to be published.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}